Kiniksa Pharmaceuticals Ltd (KNSA) — Working Capital to Net Assets Ratio
Kiniksa Pharmaceuticals Ltd (KNSA) has a Working Capital to Net Assets ratio of 72.2% as of March 2026. Working capital of $437.56 Million (current assets of $594.17 Million minus current liabilities of $156.61 Million) is measured against net assets of $605.69 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Kiniksa Pharmaceuticals Ltd net asset quality index to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Kiniksa Pharmaceuticals Ltd Working Capital to Net Assets (2016–2025)
This chart shows how Kiniksa Pharmaceuticals Ltd's Working Capital to Net Assets ratio has evolved across 10 annual periods from 2016 to 2025. As of March 2026, the ratio stands at 72.2%, reflecting working capital of $437.56 Million against net assets of $605.69 Million USD. Check tangible net worth ratio of Kiniksa Pharmaceuticals Ltd to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Kiniksa Pharmaceuticals Ltd (2016–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Kiniksa Pharmaceuticals Ltd from 2016 to 2025, covering 10 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see KNSA market cap overview.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 68.4% | $387.99 Million | $567.61 Million | $527.18 Million | $139.18 Million | ▲ +15.6 pp |
| 2024 | 52.7% | $231.18 Million | $438.44 Million | $331.80 Million | $100.62 Million | ▲ +4.3 pp |
| 2023 | 48.5% | $212.63 Million | $438.84 Million | $276.30 Million | $63.67 Million | ▼ -1.0 pp |
| 2022 | 49.5% | $195.99 Million | $396.15 Million | $243.06 Million | $47.07 Million | ▼ -32.5 pp |
| 2021 | 81.9% | $151.62 Million | $185.04 Million | $196.45 Million | $44.82 Million | ▼ -14.7 pp |
| 2020 | 96.6% | $301.40 Million | $311.94 Million | $333.25 Million | $31.85 Million | ▲ +1.8 pp |
| 2019 | 94.8% | $213.80 Million | $225.42 Million | $241.63 Million | $27.83 Million | ▼ -2.3 pp |
| 2018 | 97.1% | $271.20 Million | $279.27 Million | $313.75 Million | $42.55 Million | ▲ +130.2 pp |
| 2017 | -33.1% | $29.67 Million | $-89.71 Million | $47.10 Million | $17.43 Million | ▲ +176.9 pp |
| 2016 | -210.0% | $54.03 Million | $-25.73 Million | $56.33 Million | $2.30 Million | — |